This webinar series will familiarize participants with the recently published WHO recommendations on the use of tNGS to detect TB drug resistance and help guide clinical decision-making, adoption considerations, available resources for implementations, and the status of current efforts to improve assay performance. Early implementing high burden countries will share their experiences using tNGS including for clinical decision-making, and manufacturers of tNGS assays will be invited to share information on their products.

 

 

 

 

 

WEBINAR #1:  

The first webinar of this series took place on April 17th, 2024

Topics Included:

  • WHO recommendations on tNGS
  • adoption considerations and resources for implementation
  • country experiences using tNGSin Kyrgyzstan and Eswatini.
Embedded thumbnail for Webinar Implementing TNGS for Detection of drug-ressitand TB in high burden countries
Webinar Implementing TNGS for Detection of drug-ressitand TB in high burden countries
Embedded thumbnail for Webinaire sur l'utilisation du séquençage ciblé de nouvelle génération pour la détection de la tuberculose pharmacorésistante.
Webinaire sur l'utilisation du séquençage ciblé de nouvelle génération pour la détection de la tuberculose pharmacorésistante.